P0643
5-Propyl-2-thiouracil
≥98%
Synonyme(s) :
PTU
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
Formule empirique (notation de Hill) :
C7H10N2OS
Numéro CAS:
Poids moléculaire :
170.23
NACRES:
NA.51
PubChem Substance ID:
UNSPSC Code:
41106305
MDL number:
Assay:
≥98%
Biological source:
synthetic (organic)
Form:
powder
Solubility:
1 M NH4OH: 50 mg/mL, clear to slightly hazy, colorless to light yellow
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderbiological source
synthetic (organic)
Quality Level
assay
≥98%
form
powder
solubility
1 M NH4OH: 50 mg/mL, clear to slightly hazy, colorless to light yellow
SMILES string
CCCC1=CNC(=S)NC1=O
InChI
1S/C7H10N2OS/c1-2-3-5-4-8-7(11)9-6(5)10/h4H,2-3H2,1H3,(H2,8,9,10,11)
InChI key
RWJRFPUNLXBCML-UHFFFAOYSA-N
Application
5-Propyl-2-thiouracil (PTU) is used to induce and study mechanisms of hypothyroidism at the levels of thyroid hormone biosynthesis and gene regulation.
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Nadine Bohni et al.
PloS one, 8(5), e64006-e64006 (2013-05-24)
Natural products (NPs) are an attractive source of chemical diversity for small-molecule drug discovery. Several challenges nevertheless persist with respect to NP discovery, including the time and effort required for bioassay-guided isolation of bioactive NPs, and the limited biomedical relevance
Ayumi Nagasawa-Masuda et al.
PloS one, 12(4), e0174633-e0174633 (2017-04-04)
Vascular regression is essential to remove redundant vessels during the formation of an efficient vascular network that can transport oxygen and nutrient to every corner of the body. However, no mechanism is known to explain how major blood vessels regress
Dong Hyun Jo et al.
Molecular cancer, 12, 71-71 (2013-07-10)
With high throughput screening, novel therapeutic agents can be efficiently identified. Unfortunately, researchers only resort to in vitro cell viability assays for screening of anticancer drugs for retinoblastoma, the most common intraocular cancer in the childhood. Current available animal models